 Superiority granisetron plus prochlorperazine prevention chemotherapy-induced emesis Trials selective receptor antagonists excellent antiemetic activity chemotherapy cisplatin high-dose metoclopramide little information efficacy new agents chemotherapy high-dose cisplatin double-blind trial single dose receptor antagonist granisetron BRL single intravenous dose dexamethasone prochlorperazine patients first course emetogenic chemotherapy doxorubicin- cyclophosphamide-containing combinations first hours significant advantage granisetron group terms prevention nausea emesis difference frequency reported adverse events granisetron effective dexamethasone prochlorperazine patients emetogenic cytotoxic agents